ENTITY
SHR-3821
SHR-3821
PulseAugur coverage of SHR-3821 — every cluster mentioning SHR-3821 across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Hong Kong approves tax relief; Hengrui Medicine advances drug trials
Hong Kong's Legislative Council has approved a bill to implement tax relief measures, including one-time tax reductions and increased deductions, which will be reflected in taxpayers' assessments for the 2025/26 and 202…
-
Hengrui Medicine subsidiaries get drug trial approvals; Xiangcai merger review resumes
Hengrui Medicine announced that its subsidiaries have received approval from China's National Medical Products Administration for clinical trials of three drugs. These include SHR-3821 for advanced solid tumors, Adebeli…